Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Prior to the early 1980s, it was uncommon for children with complex congenital heart disease (cCHD) to survive into later childhood. The nearly simultaneous advances in congenital heart surgery, echocardiography, and intensive care medicine were coupled with the availability of prostaglandins and the developing discipline of interventional cardiology. Together, these factors resulted in a dramatic fall in surgical mortality, with complex repairs taking place at increasingly younger ages. At many large centers, palliative surgery followed by later repair in infants with complex biventricular cCHD was replaced by primary repair during the neonatal period or infancy. Similarly, staged reconstructive surgery for various forms of functionally univentricular heart, including those with hypoplastic left heart syndrome (HLHS), improved significantly with steadily falling rates of surgical mortality and dramatically improved long-term survival. While the ever-increasing population of child and adolescent survivors is a testament to important innovations in cCHD care, the reality is that cCHD and its treatments put the developing brain at tremendous risk for injury. Children with cCHD often require multiple surgeries and long hospitalizations, and require frequent outpatient follow-up. Survivors often suffer injury to the brain due to decreased oxygen delivery, and/or reperfusion injury related to the abnormalities of their circulatory systems and the medical and surgical therapies they have received. These brain injuries result in worse neurodevelopmental, psychosocial, and physical functioning, and cumulatively they have a significantly negative impact on the child's health-related quality of life (HRQOL). In addition, research on the academic and behavioral outcomes of children and adolescents with cCHD entering primary and secondary school has revealed a significantly increased risk for neurodevelopmental and psychosocial impairment across a broad range of domains. Many school-age survivors of infant cardiac surgery require remedial educational and rehabilitative services including tutoring, special education, and other learning supports, and physical, occupational, and speech therapy. These deficits add to the psychologic burden faced by the family.
This chapter outlines the scope of the acquired neurodevelopmental and psychosocial outcomes in cCHD survivors including: mechanisms of injury; fetal mechanisms of congenital brain disease; genetic susceptibility to neurologic injury and developmental disability; the impact of the underlying cardiac diagnosis on neurodevelopmental outcome; the effect of cardiac surgery on the brain; postoperative factors; developmental care in the intensive care unit (ICU) and early intervention; evaluation and management of neurodevelopmental outcome in children and adolescents with congenital heart disease; HRQOL; and longer-term effects of the initial ICU stay; and the effects of living with chronic cardiac disease on the patient and family. The impact of genetic syndromes on neurodevelopment as well as specific genetic abnormalities predisposing to both cCHD and neurodevelopmental delay are also briefly discussed (see also Chapters 4 and 77 ).
An estimated 3 per 1000 children are born each year with cCHD. cCHD is defined as congenital heart disease that requires surgical or catheter intervention during the neonatal period or infancy. For these children, neurodevelopmental disabilities and psychosocial issues are common, affecting at least 50% of the survivors during childhood and adolescence. The individual neurodevelopmental and psychosocial deficits or disabilities may occur in a single or a combination of domains, and may be mild or quite debilitating. Formal evaluations of preschool and school-aged children born with cCHD demonstrate a pattern of neurodevelopmental sequelae that includes: mild cognitive impairment with reduced intelligence quotient and academic achievement in math and reading; oromotor dysfunction, expressive speech and language delays; impaired visual-spatial and visual-motor skills; executive dysfunction (organization, planning, and task management); reduced working memory; inattention and hyperactivity; and fine and gross motor delays. In addition, a disproportionate number of these cCHD survivors have significant psychosocial issues, including impaired social interaction and deficits in social cognition; impaired core communication skills and an increased incidence of autism spectrum disorders; increased incidence of psychiatric disorders; and issues with behavioral and emotional functioning (anxiety, depression, posttraumatic stress symptomatology, and attention deficit hyperactivity disorder). These significant neurodevelopmental and psychosocial morbidities may significantly diminish QOL ( Box 76.1 ).
Stroke
Seizures
Abnormal brain morphology and functional connectivity (MRI)
Abnormal brain growth, cerebral atrophy (CT, MRI)
CNS hemosiderin deposition (MRI)
Cognitive impairment with lower intelligence quotient and academic achievement in math and reading
Oromotor dysfunction
Delayed gross and fine motor milestones
Decreased gross motor strength, agility, and coordination
Speech apraxia
Problems with visual–spatial and visual–motor integration
Inattention and hyperactivity
Impaired working memory
Impaired social interaction and deficits in social cognition
Impaired core communication skills and an increased incidence of autism spectrum disorders
Increased incidence of psychiatric disorders
Issues with behavioral and emotional functioning:
Anxiety
Depression
Posttraumatic stress symptomatology
Attention deficit hyperactivity disorder
CNS , Central nervous system; CT , computerized tomography; MRI , magnetic resonance imaging.
Indeed, neurodevelopmental and psychosocial challenges are often more common in children and young adults with cCHD than all cardiovascular complications combined (e.g., residual lesions, myocardial dysfunction, arrhythmias). The need for early intervention, rehabilitative services, and special education, as well as potentially worse educational attainment and employability in cCHD survivors result in significant costs to society. As children progress through school, these neuropsychologic issues, worse self-perception and self-esteem, and behavioral disinhibition, may result in delinquency and academic failure. Given these findings, there is active interest to better understanding the mechanisms of brain injury in these children, to design treatment trials to prevent the neurodevelopmental and psychosocial phenotype during the neonatal and infant period, and interventions to treat the neurodevelopmental and psychosocial phenotype in the preschool and school-age periods to improve long-term outcomes and QOL in all cCHD patients. In addition, there is active interest in adapting the techniques used to treat these disabilities in children without cCHD to this growing population.
Central nervous system (CNS) injury in children with cCHD is a result of a complex interaction of patient-specific factors and environmental influences, including, but not limited to, the effects of an abnormal fetal circulation and various interventions such as cardiac surgery and perioperative care ( Fig. 76.1 ). The risk of a poor neurodevelopmental outcome varies according to the hemodynamics and oxygen delivery to the brain associated with the specific cardiac defect, the therapies required to repair or palliate the defect, and the perioperative risk profile for brain injury. In addition, there is significant individual variation in neurodevelopmental outcome, even among children with the same cardiac defect. Although cerebral ischemia before, during, and after the surgical repair of cCHD has been proposed to be the primary mechanism of CNS injury, additional prenatal, in-hospital and latent factors during childhood may contribute to neurologic dysfunction. These factors can be broadly divided into three main categories and time frames: (1) prenatal, (2) perioperative, and (3) postdischarge. From a research perspective, it is difficult to separate out the relative contributions of these three mechanistic categories as they coexist in the majority of neonates.
There is growing recognition that the brain is abnormal at birth in the majority of neonates with cCHD. Fetal and postnatal magnetic resonance imaging (MRI) studies have identified brain immaturity at birth and a surprisingly high incidence of white matter injury (WMI), stroke, and hemmorhage. MRI and echocardiographic studies have confirmed abnormalities of cerebral vascular resistance (CVR), fetal blood flow, and reduced substrate delivery leading to immaturity of the developing brain. In addition, there is an increased incidence of congenital structural CNS abnormalities in association with cCHD, suggestive of shared (heart, brain) genetic abnormalities. In combination, these functional and anatomic abnormalities seen in the newborn with cCHD might best be considered coexisting congenital brain disease , and appear to be present in nearly 50% of these neonates.
Ultrasound studies in the fetus have revealed that CVR is altered in fetuses with cCHD. Fetuses with left-sided obstructive lesions (e.g., HLHS) have been shown to have decreased CVR compared to normal fetuses. In patients with aortic atresia, the combined fetal cardiac output from the right ventricle must travel through the ductus arteriosus and deliver flow cephalad (in a retrograde fashion) to the brain, as well as caudad to the viscera and low resistance placenta. In left-sided cCHD, it is speculated that CVR must therefore be lower than normal to allow adequate fetal blood flow cephalad to the developing brain. In contrast, fetuses with right-sided obstructive lesions (e.g., tetralogy of Fallot [TOF]), where the combined fetal cardiac output leaves the left heart and passes cephalad, through the ascending aorta, to the brain prior to reaching the placenta, have been shown to have increased fetal CVR. The altered CVR, whether higher or lower than normal, most likely has an effect on the developing brain. The changes in cerebral blood low that occur immediately after birth, when pulmonary vascular resistance abruptly falls, are incompletely understood; however, studies of cerebral blood flow in the first days of life suggest that cerebral blood flow and oxygen delivery is low, and continues to fall during this critical time period.
In the normal fetus, the intracirculatory patterns created by the normal fetal connections result in preferential streaming of the most highly oxygenated fetal blood to the developing brain, and the most desaturated blood to the placenta. When significant structural disease exists within the heart, these beneficial patterns are likely to be altered. Recently confirmed by fetal MRI measurements, fetuses with d-transposition of the great arteries (d-TGA) have the blood with the lowest oxygen saturation returning to the ascending aorta and brain, while blood with the highest oxygen saturation returns to the abdominal organs and placenta. Speculation on the consequences of the transposed fetal circulation (as an explanation for the high incidence of macrosomia in these infants) dates back more than 50 years, and has been offered as an explanation for the increased incidence of relative microcephaly and long-term developmental challenges seen so often in children with d-TGA. Complete mixing with a dual-distribution circulation (see Chapter 70 ), as seen in those with functionally univentricular hearts, and limitations on compensatory lowering of CVR, produce reduced fetal cerebral oxygen delivery. The contribution of the placenta adds complexity to the issue as it has been noted that placental weights are much lower than normal, and placental vascularity is abnormal in fetuses with cCHD. Furthermore, MRI measurements of umbilical vein oxygen saturations are significantly lower than expected, suggesting placental dysfunction (see also Chapters 7 and 11 ).
It has long been recognized that the neurologic status of newborns with cCHD is frequently abnormal prior to newborn heart surgery, including abnormalities in muscle tone, weak cry, and poor coordination of suck, swallow, and breathing. Following birth, cerebral blood flow may be significantly lower than normal in some patients due to abnormal cardiac physiology and frequently a “steal” of systemic cardiac output through the patent ductus arteriosus into the pulmonary arteries. In some lesions, such as total anomalous pulmonary venous return with obstruction and d-TGA with an intact atrial and ventricular septum, profound hypoxemia and acidosis may result immediately after birth. Certain procedures, such as balloon atrial septostomy, may be associated with an increased risk of stroke, although the data are conflicting in this regard. Genetic syndromes are present in approximately 25% of neonates with cCHD. Recent studies have suggested that genetic abnormalities may play a role in the abnormalities of brain structure, developmental delay, neurodevelopmental disability, as well as contribute to the risk of developing cCHD itself (see later). Finally, all patients with right to left shunting have the potential for air or thromboembolic material reaching the brain from intravenous catheters prior to, during, or after surgery. Hypoxemia, low cardiac output, and cardiac arrest in patients with uncorrected cCHD may contribute to CNS ischemia, injury, developmental delay, and neurodevelopmental disability, adding to the abnormalities that may be present at birth.
Head circumference at birth is a surrogate for growth of the brain in the fetus, and in neonates without cCHD, microcephaly is independently associated with later developmental delays and academic difficulties. The incidence of microcephaly at birth in neonates with cCHD is increased compared to heart-healthy neonates (approaching 25% of neonates in some reports), persists into later infancy, and is associated with later developmental abnormalities. While the causes are speculative, and most certainly multifactorial, Shillingford et al. reported on a series of children with HLHS where the median head circumference at birth was only at the 18th percentile. In this study, patients with microcephaly had a significantly smaller ascending aorta than those without microcephaly, suggesting that reduced flow to the brain from the left ventricle secondary to anatomic hypoplasia of the ascending aorta may result in diminished brain growth.
Microcephaly, structural and biochemical immaturity of the white matter, and delay in cortical folding and white matter myelination have led researchers to delve into investigations of fetal brain development. Limperopoulos et al. have shown striking differences in brain growth in fetuses with and without cCHD, with brain growth diverging from normal in the fetuses with cCHD at the beginning of the third trimester of pregnancy. Fetuses with hypoplasia of the aortic arch fared the worst, with the most reduced brain growth during the final trimester of gestation. Wu et al also showed that measures of fetal cortical complexity similarly diverged from normal during the third trimester.
WMI, in the form of periventricular leukomalacia (PVL), is a common finding in premature infants. Although WMI has been increasingly recognized in full-term neonates with cCHD, some feel strongly that the term PVL should be reserved for the premature infant. Importantly, while there may be no differences in the MRI appearance of the punctate WMI in the two populations, the WMI in the cCHD population never becomes cystic like PVL in the preterm. In premature infants, severe degrees of PVL have been associated with cerebral palsy, while mild degrees of injury have been associated with developmental delay, motor difficulties, and behavioral disorders. The developmental “phenotype” in children who were born prematurely is remarkably similar to that seen in school-age children with cCHD. Preoperative factors and patient-specific factors including the specific heart diagnosis, postnatal age at surgery, prenatal diagnosis, and genetic factors have been shown to be associated with WMI in neonates with cCHD. Ongoing research examining the relationship between cerebral vascular reactivity and autoregulation, cerebral perfusion, and the identification of sensitive and specific brain injury biomarkers may allow for real-time intraoperative and postoperative brain injury monitoring and intervention to reduce brain injury. Miller, McQuillen, and others first demonstrated alterations in white matter structure and maturation using diffusion tensor MRI. Thereafter, Licht used an MRI-based observational metric called the Total Maturation Scale, that demonstrated brain maturation in full-term presurgical infants with cCHD was equivalent, on average, to the expected brain maturation of a 35-week premature infant. Others have since shown that the Total Maturation Scale predicted not only the risk for preoperative and postoperative WMI but also abnormalities on neurodevelopmental outcome in childhood and adolescence. In a fetal lamb model, exposure of the fetal brain to low levels of oxygen delivery in the third trimester, results in a developmental arrest in oligodendrocytes resulting in populations of vulnerable premyelinating oligodendrocytes. Similarly, in infants with cCHD, during fetal development there is lower than normal oxygen delivery in the third trimester, which results in delayed brain maturation and abnormal integrity of the white matter at birth. In infants with cCHD, these changes result in their developmental vulnerability to WMI. Heart defect type, surgical strategy, and other exposures result in the injury. Lynch et al, using advanced optical techniques to quantify cerebral blood flow and oxygen saturations, showed that daily falls in cerebral oxygen saturations between birth and surgery increased the risk for postoperative WMI in babies with HLHS. In Lynch's study, rising cerebral oxygen extraction was not compensated with increasing cerebral blood flow. It is theorized that WMI results from a combination of cellular vulnerability and limitations in cerebral oxygen delivery. Similarly, Petit et al found an increased risk for WMI in neonates with d-TGA, as the duration between birth and surgery increases. These studies, and others, have challenged the paradigm of the timing of neonatal surgery. At the current time, there are competing risks of waiting longer for surgery (from a brain perspective) compared to proceeding early with surgery (from a renal, pulmonary, and cardiac perspective). See Chapter 15 for a similar discussion in the premature infant with cCHD.
While there are no prospective longitudinal studies to directly link the WMI seen in the newborn after heart surgery, with long-term (10-year outcomes or longer) neurodevelopmental outcomes or specific functional deficits, there is growing evidence that suggests that abnormal white matter is in fact at the core of these deficits. Brain MRIs obtained as part of the 16-year follow-up of the Boston Circulatory Arrest Study demonstrated that the white matter in the CHD subjects showed regions of decreased fractional anisotropy (a marker of WMI) compared to age-matched controls. Further investigations revealed that some of these areas of reduced fractional anisotropy were correlated with worse performance on the Conners 3 attention deficit–hyperactivity ADHD index, the Wechsler Individual Achievement Test mathematics composite, and visual spatial testing (visual closure). In this same cohort of adolescents with d-TGA, Panigrahy and colleagues used MRI analysis techniques, which allow testing the intactness of networks of white matter (whole-brain functional connectivity of resting state networks). The work demonstrated that worse neurocognitive function was mediated by global differences in white matter network topology, suggesting that disruptions of large-scale networks drive neurocognitive dysfunction. Interestingly, some of these large-scale networks may be abnormal even before the newborn has heart surgery.
All the above risk factors do not fully explain either the high frequency or the pattern of neurodevelopmental deficits described in children with cCHD, suggesting that other patient-specific factors may be important determinants of neurologic injury. Intelligence quotient and cognitive functioning (e.g., academic achievement in math and reading) are highly heritable and probably are dependent on multiple genes, environmental factors, and gene-environment interactions. Numerous genetic defects or syndromes that are associated with compromised intellectual capacity and developmental outcomes (e.g., trisomy 21, Williams syndrome, DiGeorge syndrome) may have cCHD as part of its phenotypic expression. Although the genetic basis for most cardiac defects has not been delineated, specific genetic anomalies have been implicated in the pathogenesis of some defects. For example, microdeletions of chromosome 22 are associated with DiGeorge syndrome and a variety of heart defects, including TOF, truncus arteriosus, and interruption of the aortic arch. Developmental abnormalities are present in all children with 22q11 microdeletions, even those with no cardiac abnormalities. Thus, children with cardiac defects and 22q11 microdeletions may be developmentally impaired independent of the cardiac defect and morbidity-related cardiac interventions. However, recent studies suggest that the effects may be additive. Recent work by Homsy and colleagues and the Pediatric Congenital Genomics Consortium, in a cohort of over 1200 parent-offspring trios, has shown an excess of protein-damaging de novo mutations, especially in genes highly expressed in the developing heart and brain. These mutations accounted for 20% of patients with cCHD, neurodevelopmental delay and additional congenital abnormalities, compared to 2% with isolated CHD.
Risk of disease or injury in response to an environmental stimulus is a complex interaction between genetic susceptibility and environmental exposures. Interindividual variation in “disease risk” and in the response to environmental factors is significant. The “risk” may be modified by age, gender, ethnicity, and the extent of exposure to environmental factors. Multiple genes are involved in determining an individual's response to a specific environmental factor. Interindividual variation in response to environmental exposures, such as cardiac surgery, probably is due in part to genetic polymorphisms. Common genetic variants, often due to single nucleotide substitutions, occur with a frequency of greater than 1%. For a child with cCHD, environmental factors include cardiac surgery, use and/or duration of deep hypothermic circulatory arrest (DHCA), inflammatory response to blood exposure to synthetic surfaces during bypass, the need for repeated operations, the response to pressor or sedating medications, and socioeconomic status (SES). The role of genetic polymorphisms in determining the susceptibility to CNS injury in children with CHD is not known. Recent studies suggest that polymorphisms of apolipoprotein e (ε2 polymorphism) may be predictors of adverse neurodevelopmental sequelae following infant cardiac surgery, and this has been similarly reported in adults with the ε4 polymorphism. Antagonistic pleiotropy is the term that describes how a polymorphism may be beneficial early but harmful later in life. It is likely that multiple genes modulate the CNS response to cardiopulmonary bypass (CPB), DHCA, and other environmental factors modifying the risk and pattern of injury.
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here